Related references
Note: Only part of the references are listed.Pathologic Complete Response after Neoadjuvant Chemotherapy and Impact on Breast Cancer Recurrence and Survival: A Comprehensive Meta-analysis
Laura M. Spring et al.
CLINICAL CANCER RESEARCH (2020)
Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients
Amirhessam Tahmassebi et al.
INVESTIGATIVE RADIOLOGY (2019)
Early PET response predicts complete response
Peter Sidaway
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter
Hanna Piotrzkowska-Wroblewska et al.
PLOS ONE (2019)
Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features
Woo Jung Choi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2019)
Sentinel Node Lymph Node Surgery After Neoadjuvant Therapy: Principles and Techniques
Jennifer M. Racz et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
The volumetric-tumour histogram-based analysis of intravoxel incoherent motion and non-Gaussian diffusion MRI: association with prognostic factors in HER2-positive breast cancer
Chao You et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Node positive breast cancer: Concordance between baseline PET/CT and sentinel node assessment after neoadjuvant therapy
Oscar Leopoldo Christin et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
Erika M. S. Negrao et al.
EUROPEAN JOURNAL OF RADIOLOGY (2019)
Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial
David C. Newitt et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)
Comparison of MRI and US in Tumor Size Evaluation of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Onur Taydas et al.
EUROPEAN JOURNAL OF BREAST HEALTH (2019)
Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy for Primary Breast Cancer Comparing Interim Ultrasound, Shear Wave Elastography and MRI
Andrew Evans et al.
ULTRASCHALL IN DER MEDIZIN (2018)
Major Reduction in Axillary Lymph Node Dissections After Neoadjuvant Systemic Therapy for Node-Positive Breast Cancer by combining PET/CT and the MARI Procedure
M. E. M. van der Noordaa et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients
Annina Baumgartner et al.
BREAST (2018)
MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis
Huimin Li et al.
BREAST (2018)
Apparent diffusion coefficient measurement in luminal breast cancer: will tumour shrinkage patterns affect its efficacy of evaluating the pathological response?
D. Zhang et al.
CLINICAL RADIOLOGY (2018)
Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer
Yunju Kim et al.
MAGNETIC RESONANCE IMAGING (2018)
Quantitative evaluation of intravoxel incoherent motion diffusion-weighted imaging (IVIM) for differential diagnosis and grading prediction of benign and malignant breast lesions
Xijin Mao et al.
MEDICINE (2018)
Do Tumor Shrinkage Patterns at Breast MR Imaging Predict Survival?
Linda Moy
RADIOLOGY (2018)
Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer
Ippei Fukada et al.
RADIOLOGY (2018)
Rethinking neoadjuvant chemotherapy for breast cancer
Jayant Vaidya et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Rethinking neoadjuvant chemotherapy for breast cancer
Jayant Vaidya et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT) A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)
Oluwadamilola M. Fayanju et al.
ANNALS OF SURGERY (2018)
Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy
Jiyoon Park et al.
EUROPEAN JOURNAL OF RADIOLOGY (2018)
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Briete X. Z. Goorts et al.
BREAST CANCER RESEARCH (2018)
RECIST-learning from the past to build the future
Saskia Litiere et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Imaging Neoadjuvant Therapy Response in Breast Cancer
Amy M. Fowler et al.
RADIOLOGY (2017)
18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging
Ana Paula Caresia Aroztegui et al.
TUMOR BIOLOGY (2017)
Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery
Audree B. Tadros et al.
JAMA SURGERY (2017)
Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
Yuka Asano et al.
BMC CANCER (2017)
Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors
ManMan Li et al.
BREAST JOURNAL (2017)
Magnetic Resonance Imaging for Axillary Breast Cancer Metastasis in the Neoadjuvant Setting: A Prospective Study
Anne E. Mattingly et al.
CLINICAL BREAST CANCER (2017)
Predictive Clinicopathologic and Dynamic Contrast-Enhanced MRI Findings for Tumor Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
Hye-Joung Eom et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer
Gaiane M. Rauch et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2017)
Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size
Young-Seon Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors
Gene Young Cho et al.
EUROPEAN RADIOLOGY (2016)
RECIST 1.1-Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
RECIST 1.1-Update and clarification: From the RECIST committee
Lawrence H. Schwartz et al.
EUROPEAN JOURNAL OF CANCER (2016)
Utility of the CPS plus EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy
Frederik Marme et al.
EUROPEAN JOURNAL OF CANCER (2016)
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Shunan Che et al.
MEDICINE (2016)
Histological assessment of therapeutic response in breast cancer
Rie Horii et al.
BREAST CANCER (2016)
The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI
Marc B. I. Lobbes et al.
JOURNAL OF CANCER (2015)
Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
A. Sheri et al.
ANNALS OF ONCOLOGY (2015)
Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer
Michael Luke Marinovich et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
Seok Mo Lee et al.
CLINICAL NUCLEAR MEDICINE (2014)
Standardized diagnosis and reporting of breast cancer
I. Thomassin-Naggara et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2014)
Magnetic resonance imaging shrinkage patterns following neoadjuvant chemotherapy for breast carcinomas with an emphasis on the radiopathological correlations
Kaori Tomida et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Study of Tumour Cellularity in Locally Advanced Breast Carcinoma on Neo-Adjuvant Chemotherapy
Swarup Kumar et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2014)
Pathological responses and long-term outcome analysis after neoadjuvant chemotheraphy in breast cancer patients from Kuwait over a period of 15 years
Yamini Krishnan et al.
ANNALS OF SAUDI MEDICINE (2013)
Imaging Response and Residual Metastatic Axillary Lymph Node Disease after Neoadjuvant Chemotherapy for Primary Breast Cancer
Tina J. Hieken et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Response-Guided Neoadjuvant Chemotherapy for Breast Cancer
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy
Nkiruka C. Atuegwu et al.
TRANSLATIONAL ONCOLOGY (2013)
Cascade Reactions Forming Highly Substituted, Conjugated Phospholes and 1,2-Oxaphospholes
Anna I. Arkhypchuk et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Defining the Benefits of Neoadjuvant Chemotherapy for Breast Cancer
Anne F. Schott et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy-Results from ACRIN 6657/I-SPY TRIAL
Nola M. Hylton et al.
RADIOLOGY (2012)
Intra- and inter-observer variability in measurement of target lesions: implication on response evaluation according to RECIST 1.1
Daniela Muenzel et al.
RADIOLOGY AND ONCOLOGY (2012)
Eat in or take away? How phosphatidylinositol 4-kinases feed the phospholipase C pathway with substrate
Elise Delage et al.
PLANT SIGNALING & BEHAVIOR (2012)
Validation of a Novel Staging System for Disease-Specific Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Elizabeth A. Mittendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment
Baris Turkbey et al.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY (2010)
Neoadjuvant Chemotherapy Shows Similar Response in Patients With Inflammatory or Locally Advanced Breast Cancer When Compared With Operable Breast Cancer: A Secondary Analysis of the GeparTrio Trial Data
Serban Dan Costa et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome
Tadahiko Shien et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective
Marc Schegerin et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer
Frederique Penault-Llorca et al.
HUMAN PATHOLOGY (2008)
Measurement of residual disease after neoadjuvant chemotherapy
Catherine Abrial et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
[18F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy
Alina Berriolo-Riedinger et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer
Judy C. Boughey et al.
ANNALS OF SURGERY (2006)
High prognostic significance of residual disease after neoadjuvant chemotherapy:: a retrospective study in 710 patients with operable breast cancer
S Amat et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Neoadjuvant chemotherapy in breast cancer
H Charfare et al.
BRITISH JOURNAL OF SURGERY (2005)
Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response
R Rajan et al.
CANCER (2004)
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: Preliminary results from national surgical adjuvant breast and bowel project protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
KN Ogston et al.
BREAST (2003)
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate
S Amat et al.
BRITISH JOURNAL OF CANCER (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
